1. Background
Atopic dermatitis (AD), perpetuated by gene-environmental reciprocal action, is the most common type of dermatosis in infants and children, and has the characteristics of genetic barrier defects and allergic inflammation (1, 2). The number of patients with AD is continuing to increase in many developed and developing countries (3, 4). According to the International Study of asthma and allergies in childhood (ISAAC), the prevalence of AD is 10% to 20% in children and 1% to 3% in adults worldwide (2). The lifetime prevalence of pruritus eczema in children aged 6 to 7 years has increased from 17.1% to 27.0%, while within 12 months this prevalence has increased from 13.4% to 20.6% (5, 6). Because of the increasing prevalence of AD, complications from recurrent bacterial and viral skin infections are also on the rise (7). Atopic Dermatitis complications are usually not life-threatening conditions, yet, a few associated conditions, such as hypoalbuminemia, could be dangerous to patients (8, 9).
Hypoalbuminemia is caused by epidermal permeability barrier defects in patients with AD and may occur when taking herbal medicine or restricting milk formula for AD treatment in children (10). Hypoalbuminemia is usually accompanied by hypoproteinemia and thrombocytosis. As a result, hypoalbuminemia can be a life-threatening condition owing to hypovolemic shock combined with hypoproteinemia and vascular infarction caused by thrombocytosis (11-13).
However, because hypoalbuminemia has a low prevalence, there have been only a few studies of hypoalbuminemia in children with AD.
2. Objectives
The aim of this study was to evaluate correlations between clinical features and laboratory test results of AD children with scoring atopic dermatitis (SCORAD) score of ≥ 40, according to the presence of hypoalbuminemia.
3. Methods
3.1. Participants
The study population consisted of patients between 3 and 24 months of age, referred to the pediatric allergy and respiratory center at Mary’s Hospital, Busan, South Korea, because of an itching sensation, dry skin, weeping, and edema. These patients were diagnosed with severe AD by allergy specialists between June 2007 and March 2016. The study was approved by the institutional review board at St. Mary’s Hospital in Busan, South Korea.
Diagnosis of AD was made in accordance with the diagnostic criteria proposed by Hanifin and Rajka (14) and the SCORAD score was calculated by allergy specialists. Moderate to severe AD was defined as SCORAD score of ≥ 40 (15). A blood albumin level of ≤ 3.5 g/dL (16) on the first day of admission was considered as hypoalbuminemia. Patients with chronic or kidney diseases (bronchopulmonary dysplasia, congestive heart disease, nephrotic syndrome, etc.) were excluded from the study. Children with moderate to severe AD (n = 82) were categorized to two groups, hypoalbuminemia (n = 27) and non-hypoalbuminemia (n = 55).
3.2. Laboratory Tests
The levels of Eosinophil Cationic protein (ECP), total immunoglobulin E (IgE), and specific IgE (sIgE), as well as peripheral blood eosinophil count were assayed on the first day of admission. Levels of ECP, total IgE, and sIgE for allergens were measured using Immuno CAP 250 (Thermo Fisher, Uppsala, Sweden). A sIgE level of > 0.7 kUA/L was used to define sensiti-vity to house dust mites (Dermatophagoides pteronyssinus and Dermatophagoides farinae) and foods (eggs, milk, soybeans, and peanuts). Peripheral blood eosinophil counts were measured using an automated hematology analyzer (Coulter Counter STKS; Beckman Coulter, Fullerton, CA, USA), using blood samples collected in Ethylenediaminetetraacetic Acid (EDTA) tubes.
3.3. Skin Culture
Before AD treatment, a skin swab test was taken from inflamed, pus-filled, or oozing areas. One swab was collected per patient and transported to the laboratory. Swabs were inoculated directly onto blood agar plates and incubated at 35°C for 24 hours before being examined. If there were specific yellow colonies, a test of catalase and coagulase using VITEC 2 (Biomerius Inc., Durham, NC, USA) was conducted to classify Staphylococcus aureus. After using VITEC 2, according to the national committee for clinical laboratory standards, the minimal inhibitory concentration (MIC) was also determined. If the MIC to oxacillin was ≥ 4 μg/mL, S. aureus colonies were classified as Methicillin-Resistant S. aureus (MRSA).
3.4. Statistical Analysis
All statistical analyses were performed using IBM SPSS version 21.0 (IBM Co., Armonk, NY, USA). The experiment-tal results are presented as arithmetic mean ± standard deviation. One-way analysis of variance was used for continuous variables to assess intergroup differ-ences. Multivariate logistic regression analysis was used to identify risk factors for hypoalbuminemia, and Odds Ratios (OR) and 95% Confidence Interval (CI) were calculated. Values of P < 0.05 were considered statistically significant.
4. Results
The clinical characteristics of both groups are shown in Table 1. Significant differences were observed in gender, average age, age at AD onset, and duration of AD between the groups. Hypoalbuminemia group was extremely male dominant, whereas non-hypoalbuminemia group had approximately equal proportion of males and females. No significant differences were observed in delivery method, average body weight, average body weight percentile, parental allergic disease history, or SCORAD score (P > 0.05).
Table 1.Clinical Characteristics of the Study Groupsa
| Parameters | Hypoalbuminemia, (n = 27) | Non- hypoalbuminemia, (n = 55) | P Value |
|---|---|---|---|
| Gender, No. (%) | 0.002 | ||
| Male | 24 (88.9) | 30 (54.5) | |
| Female | 3 (11.1) | 25 (45.5) | |
| Age, mo | 7.22 ± 2.90 | 10.78 ± 6.15 | < 0.001 |
| Vaginal delivery, No. (%) | 16 (59.3) | 32 (58.2) | 0.926 |
| Weight, kg | 8.15 ± 1.57 | 9.35 ± 1.65 | 0.884 |
| Weight percentile | 40.37 ± 31.84 | 56.31 ± 27.51 | 0.467 |
| Parental allergic disease, No. (%) | 22 (81.5) | 37 (67.3) | 0.178 |
| Allergic rhinitis | 14 (51.9) | 29 (52.7) | 0.941 |
| Atopic dermatitis | 3 (11.1) | 8 (14.5) | 0.668 |
| Age at AD onset, mo | 4.44 ± 2.41 | 8.38 ± 5.34 | < 0.001 |
| Duration of AD, No. (%) | 0.018 | ||
| < 1 years | 27 (100) | 45 (81.8) | |
| ≥ 1 years | 0 (0.0) | 10 (18.2) | |
| SCORAD score | 53.73 ± 13.87 | 53.36 ± 10.68 | 0.386 |
Abbreviations: AD, atopic dermatitis; SCORAD, Scoring Atopic Dermatitis.
aValues are presented as mean ± standard deviation.
The laboratory test results of both groups are shown in Table 2. Serum white blood cell and platelet counts were significantly higher in hypoalbuminemia group. Serum C-reactive protein, total protein, and albumin levels were lower in hypoalbuminemia group, yet, the difference was significant only for albumin. Serum total IgE and ECP levels, and total eosinophil counts were significantly higher in the hypoalbuminemia group (P < 0.001). Concerning positive skin culture results, there was no statistically significant difference between the groups (P = 0.526). However, the hypoalbuminemia group had a significantly higher proportion of positive MRSA results than non-hypoalbuminemia group (P = 0.008).
Table 2.Comparison of Laboratory Test Results Between Hypoalbuminemia and Non-Hypoalbuminemia Groupsa
| Parameters | Hypoalbuminemia, (n = 27) | Non- hypoalbuminemia, (n = 55) | P Value |
|---|---|---|---|
| White blood cell count, /mL | 23,617.81 ± 6,424.56 | 11,131.27 ± 4,103.35 | 0.033 |
| Platelet, 103/µL | 677.15 ± 206.24 | 395.38 ± 119.49 | 0.037 |
| C-reactive protein, mg/dL | 2.62 ± 6.02 | 2.80 ± 5.72 | 0.971 |
| Total protein, g/dL | 4.55 ± 0.59 | 6.36 ± 0.45 | 0.246 |
| Albumin, g/dL | 2.88 ± 0.45 | 4.32 ± 0.23 | < 0.001 |
| Total IgE, IU/mL | 1,066.07 ± 921.04 | 220.71 ± 496.59 | < 0.001 |
| ECP, µg/L | 121.39 ± 83.83 | 23.08 ± 26.86 | < 0.001 |
| Total eosinophil count, /µL | 5,648.52 ± 3,616.18 | 784.19 ± 777.87 | < 0.001 |
| Positive skin culture, No. (%) | 26 (96.2) | 51 (92.7) | 0.526 |
| MRSA | 11 (40.7) | 8 (14.5) | 0.008 |
| MSSA | 13 (48.1) | 16 (29.1) | 0.090 |
Abbreviations: ECP, Eosinophil Cationic Protein; Ige, Immunoglobulin E; MRSA, Methicillin-Resistant Staphylococcus Aureus; MSSA, Methicillin-Sensitive Staphylococcus Aureus.
aValues are presented as mean ± standard deviation.
The allergy laboratory test results of both groups are shown in Table 3. The hypoalbuminemia group had a significantly higher proportion of positive test results for allergens. The hypoalbuminemia group also had a significantly higher proportion of children with multiple allergen sensitizations. The hypoalbuminemia group had a significantly higher proportion of children with milk, eggs, peanuts, soybeans, or house dust mite allergen sensitizations. Furthermore, the levels of specific IgEs to milk, eggs, peanuts, soybeans, and house dust mite were significantly higher in the hypoalbuminemia group.
Table 3.Comparison of Allergic Laboratory Test Results Between Hypoalbuminemia and Non-Hypoalbuminemia Groupsa
| Parameters | Hypoalbuminemia, (n = 27) | Non- Hypoalbuminemia, (n = 55) | P Value |
|---|---|---|---|
| Numbers of positive to allergen, No. (%) | 26 (96.3) | 28 (50.9) | < 0.001 |
| Mono | 1 (3.7) | 8 (14.5) | |
| Poly | 25 (92.6) | 20 (36.4) | |
| Positive to allergen, No. (%) | |||
| Eggs | 23 (85.2) | 26 (47.3) | 0.001 |
| Milk | 22 (81.5) | 14 (25.5) | < 0.001 |
| Peanuts | 19 (70.4) | 10 (18.2) | < 0.001 |
| Soybean | 21 (77.8) | 12 (21.8) | < 0.001 |
| HDM | 16 (59.3) | 4 (7.3) | < 0.001 |
| Specific IgE (kUA/L) | |||
| Specific IgE to eggs | 52.97 ± 39.65 | 11.54 ± 25.52 | < 0.001 |
| Specific IgE to milk | 22.91 ± 32.46 | 3.72 ± 12.65 | < 0.001 |
| Specific IgE to peanuts | 30.45 ± 35.15 | 3.52 ± 11.10 | < 0.001 |
| Specific IgE to soybean | 28.07 ± 39.91 | 3.12 ± 5.15 | < 0.001 |
| Specific IgE to HDM | 12.77 ± 28.39 | 3.76 ± 18.88 | < 0.001 |
Abbreviations: HDM, House Dust Mite; IgE, Immunoglobulin E.
aValues are presented as mean ± standard deviation.
The relationship between the development of hypoalbuminemia and associated factors is shown in Table 4. After adjusting for age and gender, male gender (odds ratio (OR) 5.962; 95% confidence interval (CI) 2.136 to 16.644, P = 0.001) and, positive MRSA (OR, 10.625; 95% CI, 2.823 to 39.982, P < 0.001) and allergen (OR, 4.622; 95% CI, 1.573 to 13.578, P = 0.005) test results were strongly related to the presence of hypoalbuminemia.
Table 4.The Relationship Between the Development of Hypoalbuminemia and Associated Factors
| Variable | OR (95% CI) | P Value | aOR (95% CI)a | P Value |
|---|---|---|---|---|
| Male gender | 6.667 (2.446 - 18.169) | < 0.001 | 5.962 (2.136 - 16.644) | 0.001 |
| Age. mo | 1.142 (1.037 - 1.259) | 0.007 | 1.129 (1.016 - 1.254) | 0.024 |
| Total IgE, IU/mL | 0.998 (0.998 - 0.999) | < 0.001 | 0.999 (0.998 - 0.999) | 0.002 |
| ECP, µg/L | 0.976 (0.967 - 0.985) | < 0.001 | 0.976 (0.964 - 0.987) | < 0.001 |
| Total eosinophil count, /µL | 0.999 (0.998 - 0.999) | < 0.001 | 0.999 (0.998 - 0.999) | < 0.001 |
| Positive MRSA | 4.727 (1.805 - 12.382) | 0.002 | 10.625 (2.823 - 39.982) | < 0.001 |
| Positive allergen | 14.718 (3.284 - 65.964) | < 0.001 | 4.622 (1.573 - 13.578) | 0.005 |
Abbreviations: aOR, Adjusted Odds Ratio; CI, Confidence Interval; ECP, Eosinophil Cationic Protein; MRSA, Methicillin-Resistant Staphylococcus Aureus; OR, Odds Ratio.
aAdjusted for gender and age.
5. Discussion
According to the presence of hypoalbuminemia, the data presented here shows a clear difference in clinical and laboratory test results in children with moderate to severe AD. Almost 90% of the children with hypoalbuminemia were male, and younger at the onset of AD, and had a shorter AD duration compared with the children without hypoalbuminemia. One would expect longer duration of AD in hypoalbuminemia group because of complications of allergen sensitization and increased MRAS. However, our findings that indicate hypoalbuminemia occurred mainly in male infants with AD, who were diagnosed recently, correlates with previous studies (9-13).
Almost all of the children with hypoalbuminemia in previous studies had an extremely low body weight. However, children with hypoalbuminemia in this study had almost average weight percentile, and 5 of 27 children weighed within the third percentile (9-13). Therefore, we concluded that children with normal body weight could also have hypoalbuminemia as an AD complication.
Hypoalbuminemia can occur with hypoproteinemia (9, 11, 13). Thrombocytosis was recently described as a complication of severe childhood AD with hypoproteinemia (17-19). Hypovolemia associated with hypoproteinemia may also play a role in increased platelet counts and increase the risk of thrombosis. In other studies, an infant with severe AD and hypoalbuminemia had leukocytosis, and > 60% of the patients with hypoproteinemia also had thrombocytosis and leukocytosis (11, 17). The studies also showed that almost 90% of children with hypoalbuminemia had thrombocytosis and leukocytosis.
In a previous study, AD children with hypoalbuminemia or hypoproteinemia had high serum total IgE and eosinophil counts as well as specific IgE antibodies to food (11). In the present study, children with hypoalbuminemia had higher serum total IgE and ECP levels, and eosinophil counts than those without hypoalbuminemia. There must be more possible mechanisms by which children with moderate to severe AD with hypoalbuminemia develop elevated IgE or ECP or eosinophil count. However, due to the retrospective nature of the study we could not clarify the acting mechanisms. Therefore, more studies are needed to evaluate these mechanisms.
The children with hypoalbuminemia had very strong sensitivities to milk and eggs in this study. The presence of food allergy or diet restriction is an important factor in evaluating the relationship among hypoalbuminemia, food allergy, and diet in children with severe AD. However, our study design was not able to provide information about presence of food allergy or diet restriction.
Concerning skin culture results, children with AD with hypoalbuminemia or without hypoalbuminemia had high numbers of cutaneous infections in this study. Children with AD have high rates of S. aureus infection compared with those without AD (20, 21). The two groups in this study did not have significant differences in positive skin results. However, MRSA infection that was more common in the children with hypoalbuminemia was strongly associated with the presence of hypoalbuminemia. Therefore, we assumed that MRSA infection influences skin barrier, and, as a result, hypoalbuminemia appears. More studies are needed to evaluate the relationship between AD and hypoalbuminemia, and MRSA infection.
The current study had a few limitations. Firstly, only 27 subjects with SCORAD score ≥ 40 with hypoalbuminemia, were between 3 and 24 months of age, which is not a large number. Hypoalbuminemia is not a common complication of AD and we included only those children, who visited the allergy center over 9 years. Therefore, we could not obtain more subjects although 27 subjects are not too small to reach objectivity. Secondly, owing to its retrospective nature, we could not obtain enough information about the presence of food allergy or diet restriction.
However, this study has identified characteristics of children with SCORAD score of ≥ 40 with hypoalbuminemia, including clinical features and laboratory test results. In other words, male gender, positive MRSA, and allergen are factors influencing hypoalbuminemia in Korean AD children. These findings suggest that AD in children with SCORAD score ≥ 40 and hypoalbuminemia is associated with increased complications.
